- Home
- TENX vs CSCI Comparison
TENX vs CSCI Comparison
Compare TENX & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- CSCI
- Stock Information
- Founded
- TENX 1967
- CSCI 1990
- Country
- TENX United States
- CSCI Canada
- Employees
- TENX N/A
- CSCI N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- TENX Health Care
- CSCI
- Exchange
- TENX Nasdaq
- CSCI NYSE
- Market Cap
- TENX 21.6M
- CSCI 10.6M
- IPO Year
- TENX N/A
- CSCI 1996
- Fundamental
- Price
- TENX $5.90
- CSCI $3.59
- Analyst Decision
- TENX Strong Buy
- CSCI
- Analyst Count
- TENX 3
- CSCI 0
- Target Price
- TENX $16.00
- CSCI N/A
- AVG Volume (30 Days)
- TENX 40.6K
- CSCI 2.2K
- Earning Date
- TENX 08-12-2025
- CSCI 08-12-2025
- Dividend Yield
- TENX N/A
- CSCI N/A
- EPS Growth
- TENX N/A
- CSCI N/A
- EPS
- TENX N/A
- CSCI N/A
- Revenue
- TENX N/A
- CSCI $9,030,000.00
- Revenue This Year
- TENX N/A
- CSCI N/A
- Revenue Next Year
- TENX N/A
- CSCI N/A
- P/E Ratio
- TENX N/A
- CSCI N/A
- Revenue Growth
- TENX N/A
- CSCI 36.51
- 52 Week Low
- TENX $2.80
- CSCI $1.96
- 52 Week High
- TENX $7.89
- CSCI $6.77
- Technical
- Relative Strength Index (RSI)
- TENX 60.05
- CSCI N/A
- Support Level
- TENX $5.77
- CSCI N/A
- Resistance Level
- TENX $5.96
- CSCI N/A
- Average True Range (ATR)
- TENX 0.32
- CSCI 0.00
- MACD
- TENX 0.03
- CSCI 0.00
- Stochastic Oscillator
- TENX 46.81
- CSCI 0.00
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.